{"organizations": [], "uuid": "6872cb5122e85320fa4e518b9d0540fe9ab142db", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180221.html", "section_title": "Archive News &amp; Video for Wednesday, 21 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-indias-lupin-gets-us-fda-nod-for-g/brief-indias-lupin-gets-u-s-fda-nod-for-generic-tamiflu-idUSFWN1QB09G", "country": "US", "domain_rank": 408, "title": "BRIEF-India's Lupin Gets U.S. ‍FDA Nod For Generic Tamiflu", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.975, "site_type": "news", "published": "2018-02-21T16:25:00.000+02:00", "replies_count": 0, "uuid": "6872cb5122e85320fa4e518b9d0540fe9ab142db"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-indias-lupin-gets-us-fda-nod-for-g/brief-indias-lupin-gets-u-s-fda-nod-for-generic-tamiflu-idUSFWN1QB09G", "ord_in_thread": 0, "title": "BRIEF-India's Lupin Gets U.S. ‍FDA Nod For Generic Tamiflu", "locations": [], "entities": {"persons": [{"name": "sou", "sentiment": "negative"}], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "reuters) - lupin ltd", "sentiment": "neutral"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 21 (Reuters) - Lupin Ltd:\n* GETS U.S. ‍FDA APPROVAL FOR GENERIC TAMIFLU FOR ORAL SUSPENSION​ Source text - bit.ly/2sPD9z5 Further company coverage:\n ", "external_links": ["http://bit.ly/2sPD9z5", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-21T16:25:00.000+02:00", "crawled": "2018-02-22T17:45:19.000+02:00", "highlightTitle": ""}